Government of CanadaPublic Health Agency of Canada / Agency de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors HealthSurveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

 

Volume: 23S2 • March 1997

AN INTEGRATED PROTOCOL TO MANAGE HEALTH CARE WORKERS EXPOSED TO BLOODBORNE PATHOGENS


Recommendations for an Integrated Protocol

5. Post-Exposure Prophylaxis for the HCW (Table 4)

Table 4
Post-exposure prophylaxis for the HCW, if the source is positive or status is
unknown or is negative but has risk factors
Bloodborne
Pathogens
PROPHYLAXIS FOR THE HCW
HBV
  • No further action is needed if the HCW is immune + to HBV (This is presently under review by NACI.)

  • Give hepatitis B immune globulin (HBIG), preferably within 48 hours of exposure (efficacy decreases with time and is unknown after 7 days (14) ) if the HCW is susceptible + to HBV or has an unknown + status. In addition, start HB vaccine for HCWs who are susceptible + to HBV and have not received HB vaccine. Provide a single dose of vaccine for HCWs who have an unknown + status after HB vaccine ++ .

  • Give one dose of HBIG, preferably within 48 hours and another in 1 month if the HCW is a known non-responder + to the HB immunization series.

  • Draw blood for testing before HBIG or immunization is given.
HCV
  • Effective post-exposure prophylaxis is not available at this time. Immunoglobulin is not effective (9) .
HIV
  • Consider immediate post-exposure chemoprophylaxis (see Appendix).
+ See Section 7.
++ Note: Testing an exposed HCW (of " unknown + HBV status" at the time of exposure but who has received a complete series of HB vaccine or who has a history of unspecified clinical hepatitis) for HBV markers on an urgent basis may clarify the status of such a HCW regarding HBV and this may, in some cases, alter the post-exposure prophylaxis used. While not necessary in this protocol, individual agencies could consider such testing for these specific HCWs if they are able to know the test results and provide applicable post-exposure prophylaxis within 48 hours of exposure. Otherwise, post-exposure prophylaxis will need to be based on information about the HCW's status available at the time of exposure.

 

[Previous] [Table of Contents] [Next]

Last Updated: 1997-03-13 Top